ARTICLE | Company News
Bausch named 'stalking horse' in Synergy auction
December 21, 2018 7:29 PM UTC
Bausch Health Companies Inc. (TSX:BHC; NYSE:BHC) bid $200 million to acquire selected assets of Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) in a court-supervised bankruptcy auction, including global rights to gastrointestinal drug Trulance plecanatide.
The agreement makes Bausch the "stalking horse" bidder for those assets...